{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T10:04:37Z","timestamp":1789725877004,"version":"4.0.1"},"reference-count":43,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T00:00:00Z","timestamp":1780617600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","heartrhythmopen.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heart Rhythm O2"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.hroo.2026.03.039","type":"journal-article","created":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T00:04:12Z","timestamp":1780963452000},"page":"1796-1799","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Top developments in clinical cardiac electrophysiology\u20132025"],"prefix":"10.1016","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6044-045X","authenticated-orcid":false,"given":"Brian","family":"Olshansky","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.hroo.2026.03.039_bib1","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.jacc.2025.10.051","article-title":"Multicenter study on the safety of pulsed field ablation in over 40,000 patients: MANIFEST-US","volume":"87","author":"Turagam","year":"2026","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hroo.2026.03.039_bib2","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1016\/j.hroo.2025.07.103","article-title":"Pulsed field ablation vs sham ablation to treat atrial fibrillation (the PFA-SHAM trial)","volume":"6","author":"Osmancik","year":"2025","journal-title":"Heart Rhythm O2"},{"key":"10.1016\/j.hroo.2026.03.039_bib3","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1001\/jama.2024.17921","article-title":"Pulmonary vein isolation vs sham intervention in symptomatic atrial fibrillation: the SHAM-PVI randomized clinical trial","volume":"332","author":"Dulai","year":"2024","journal-title":"JAMA"},{"key":"10.1016\/j.hroo.2026.03.039_bib4","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1056\/NEJMoa2509688","article-title":"Antithrombotic therapy after successful catheter ablation for atrial fibrillation","volume":"394","author":"Verma","year":"2026","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hroo.2026.03.039_bib5","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1001\/jama.2025.14679","article-title":"Long-term anticoagulation discontinuation after catheter ablation for atrial fibrillation: the ALONE-AF randomized clinical trial","volume":"334","author":"Kim","year":"2025","journal-title":"JAMA"},{"key":"10.1016\/j.hroo.2026.03.039_bib6","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/s11883-025-01376-x","article-title":"Highlights of cardiovascular disease prevention studies presented at the 2025 American Heart Association Scientific Sessions","volume":"28","author":"Abdul Jabbar","year":"2026","journal-title":"Curr Atheroscler Rep"},{"key":"10.1016\/j.hroo.2026.03.039_bib7","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.1111\/jce.15803","article-title":"Lifestyle changes in atrial fibrillation management and intervention","volume":"34","author":"Yang","year":"2023","journal-title":"J Cardiovasc Electrophysiol"},{"key":"10.1016\/j.hroo.2026.03.039_bib8","doi-asserted-by":"crossref","DOI":"10.1093\/europace\/euaf318","article-title":"Transforming atrial fibrillation management by targeting comorbidities and reducing atrial fibrillation burden: the 10th AFNET\/EHRA consensus conference","volume":"27","author":"Svennberg","year":"2025","journal-title":"Europace"},{"key":"10.1016\/j.hroo.2026.03.039_bib9","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.jacc.2025.04.042","article-title":"Catheter ablation vs lifestyle modification with antiarrhythmic drugs to treat atrial fibrillation: PRAGUE-25 trial","volume":"86","author":"Osmancik","year":"2025","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hroo.2026.03.039_bib10","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1001\/jama.2025.21056","article-title":"Caffeinated coffee consumption or abstinence to reduce atrial fibrillation: the DECAF randomized clinical trial","volume":"335","author":"Wong","year":"2026","journal-title":"JAMA"},{"key":"10.1016\/j.hroo.2026.03.039_bib11","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1161\/CIRCULATIONAHA.125.077447","article-title":"Dapagliflozin to reduce early recurrence after catheter ablation for atrial fibrillation: the DARE-AF randomized clinical trial","volume":"153","author":"Jiang","year":"2026","journal-title":"Circulation"},{"key":"10.1016\/j.hroo.2026.03.039_bib12","doi-asserted-by":"crossref","DOI":"10.1093\/europace\/euaf284","article-title":"Management of device-detected subclinical atrial fibrillation: a European Heart Rhythm Association survey","volume":"27","author":"Meynet","year":"2025","journal-title":"Europace"},{"key":"10.1016\/j.hroo.2026.03.039_bib13","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1056\/NEJMoa2310234","article-title":"Apixaban for stroke prevention in subclinical atrial fibrillation","volume":"390","author":"Healey","year":"2024","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hroo.2026.03.039_bib14","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1056\/NEJMclde2411897","article-title":"Anticoagulation or antiplatelet therapy for device-detected atrial fibrillation","volume":"392","author":"Gorey","year":"2025","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hroo.2026.03.039_bib15","doi-asserted-by":"crossref","DOI":"10.1093\/europace\/euaf019","article-title":"Atrial fibrillation burden in clinical practice, research, and technology development: a clinical consensus statement of the European Society of Cardiology Council on Stroke and the European Heart Rhythm Association","volume":"27","author":"Doehner","year":"2025","journal-title":"Europace"},{"key":"10.1016\/j.hroo.2026.03.039_bib16","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/j.hroo.2024.09.018","article-title":"Use of continuous cardiac monitoring to assess the influence of atrial fibrillation burden and patterns on patient symptoms and healthcare utilization: the DEFINE AFib study","volume":"5","author":"Lakkireddy","year":"2024","journal-title":"Heart Rhythm O2"},{"key":"10.1016\/j.hroo.2026.03.039_bib17","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1001\/jamacardio.2025.4151","article-title":"Major bleeding with apixaban vs aspirin: a subanalysis of the ARTESiA randomized clinical trial","volume":"10","author":"Siegal","year":"2025","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.hroo.2026.03.039_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.ahj.2025.09.005","article-title":"Catheter-based left atrial appendage CLOSURE in patients with atrial fibrillation at high risk of stroke and bleeding as compared to best medical therapy: rationale and design of the prospective randomized CLOSURE-AF trial","volume":"292","author":"Landmesser","year":"2026","journal-title":"Am Heart J"},{"key":"10.1016\/j.hroo.2026.03.039_bib19","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s11886-025-02331-7","article-title":"Leadless devices: the future of pacing","volume":"28","author":"Furman","year":"2025","journal-title":"Curr Cardiol Rep"},{"key":"10.1016\/j.hroo.2026.03.039_bib20","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.1016\/j.hrthm.2025.04.030","article-title":"First-in-human study of a leadless pacemaker system for left bundle branch area pacing","volume":"22","author":"Reddy","year":"2025","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hroo.2026.03.039_bib21","doi-asserted-by":"crossref","first-page":"2028","DOI":"10.1016\/j.hrthm.2025.04.005","article-title":"Left bundle branch area pacing compared with biventricular pacing for cardiac resynchronization therapy in patients with left ventricular ejection fraction <\/=50%: results from the International Collaborative LBBAP Study (I-CLAS)","volume":"22","author":"Morcos","year":"2025","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hroo.2026.03.039_bib22","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1016\/j.hrthm.2024.09.030","article-title":"Conduction system pacing compared with biventricular pacing for cardiac resynchronization therapy in patients with heart failure and mildly reduced left ventricular ejection fraction: Results From International Collaborative LBBAP Study (I-CLAS) Group","volume":"22","author":"Vijayaraman","year":"2025","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hroo.2026.03.039_bib23","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/j.jacc.2023.12.021","article-title":"Sports participation by athletes with cardiovascular disease","volume":"83","author":"Martinez","year":"2024","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hroo.2026.03.039_bib24","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.tcm.2024.09.004","article-title":"Vigorous exercise and sports participation in individuals with hypertrophic cardiomyopathy","volume":"35","author":"Gray","year":"2025","journal-title":"Trends Cardiovasc Med"},{"key":"10.1016\/j.hroo.2026.03.039_bib25","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1161\/CIRCULATIONAHA.123.067590","article-title":"Vigorous exercise in patients with congenital long QT syndrome: results of the prospective, observational, multinational LIVE-LQTS study","volume":"150","author":"Lampert","year":"2024","journal-title":"Circulation"},{"key":"10.1016\/j.hroo.2026.03.039_bib26","doi-asserted-by":"crossref","first-page":"e151","DOI":"10.1016\/j.hrthm.2024.05.018","article-title":"HRS expert consensus statement on arrhythmias in the athlete: evaluation, treatment, and return to play","volume":"21","author":"Lampert","year":"2024","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hroo.2026.03.039_bib27","doi-asserted-by":"crossref","DOI":"10.2196\/73846","article-title":"AI-driven real-time monitoring of cardiovascular conditions with wearable devices: scoping review","volume":"13","author":"Abedi","year":"2025","journal-title":"JMIR MHealth UHealth"},{"key":"10.1016\/j.hroo.2026.03.039_bib28","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.3390\/biomedicines13071685","article-title":"Artificial intelligence and ECG: a new frontier in cardiac diagnostics and prevention","volume":"13","author":"Bartusik-Aebisher","year":"2025","journal-title":"Biomedicines"},{"key":"10.1016\/j.hroo.2026.03.039_bib29","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2025.1612750","article-title":"Machine learning algorithms for predicting atrial fibrillation using single-lead data derived from 12-lead ECGs","volume":"12","author":"Choi","year":"2025","journal-title":"Front Cardiovasc Med"},{"key":"10.1016\/j.hroo.2026.03.039_bib30","doi-asserted-by":"crossref","first-page":"3162","DOI":"10.3390\/diagnostics15243162","article-title":"Diagnostic accuracy of wearable ECG devices for atrial fibrillation and ST-segment changes: a systematic review","volume":"15","author":"Singeap","year":"2025","journal-title":"Diagnostics (Basel)"},{"key":"10.1016\/j.hroo.2026.03.039_bib31","doi-asserted-by":"crossref","DOI":"10.2196\/78075","article-title":"Photoplethysmography-based machine learning approaches for atrial fibrillation burden: algorithm development and validation","volume":"9","author":"Wang","year":"2025","journal-title":"JMIR Cardio"},{"key":"10.1016\/j.hroo.2026.03.039_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.jacadv.2025.102133","article-title":"Accuracy of smartwatches in the detection of atrial fibrillation: a systematic review and diagnostic meta-analysis","volume":"4","author":"Barrera","year":"2025","journal-title":"JACC Adv"},{"key":"10.1016\/j.hroo.2026.03.039_bib33","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.pcad.2020.03.010","article-title":"Postural Orthostatic Tachycardia Syndrome (POTS): a critical assessment","volume":"63","author":"Olshansky","year":"2020","journal-title":"Prog Cardiovasc Dis"},{"key":"10.1016\/j.hroo.2026.03.039_bib34","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/s10286-024-01020-9","article-title":"Randomized controlled trial of intravenous immunoglobulin for autoimmune postural orthostatic tachycardia syndrome (iSTAND)","volume":"34","author":"Vernino","year":"2024","journal-title":"Clin Auton Res"},{"key":"10.1016\/j.hroo.2026.03.039_bib35","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.jacc.2025.09.1608","article-title":"Association of autonomic dysfunction with long COVID: evaluation using quantitative autonomic testing","volume":"87","author":"Keller","year":"2026","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hroo.2026.03.039_bib36","doi-asserted-by":"crossref","first-page":"e449","DOI":"10.1161\/CIR.0000000000001290","article-title":"Cardiac arrhythmias and autonomic dysfunction associated with COVID-19: A scientific statement from the American Heart Association","volume":"150","author":"Gopinathannair","year":"2024","journal-title":"Circulation"},{"key":"10.1016\/j.hroo.2026.03.039_bib37","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.jacc.2025.09.1595","article-title":"Catheter ablation vs sotalol or amiodarone for ventricular tachycardia: A substudy of the VANISH2 trial","volume":"87","author":"Nery","year":"2026","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hroo.2026.03.039_bib38","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1056\/NEJMoa2409501","article-title":"Catheter ablation or antiarrhythmic drugs for ventricular tachycardia","volume":"392","author":"Sapp","year":"2025","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hroo.2026.03.039_bib39","doi-asserted-by":"crossref","first-page":"euaf139","DOI":"10.1093\/europace\/euaf139","article-title":"Safety and efficacy of a lattice-tip catheter for ventricular arrhythmia ablation: the AFFERA Ventricular Arrhythmia Ablation Registry (AVAAR)","volume":"27","author":"Sacher","year":"2025","journal-title":"Europace"},{"key":"10.1016\/j.hroo.2026.03.039_bib40","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1093\/ehjdh\/ztaf061","article-title":"The hope and the hype of artificial intelligence for syncope management","volume":"6","author":"Johnston","year":"2025","journal-title":"Eur Heart J Digit Health"},{"key":"10.1016\/j.hroo.2026.03.039_bib41","doi-asserted-by":"crossref","DOI":"10.1016\/j.jacadv.2023.100323","article-title":"Can artificial intelligence enhance syncope management?: a JACC: advances multidisciplinary collaborative statement","volume":"2","author":"Statz","year":"2023","journal-title":"JACC Adv"},{"key":"10.1016\/j.hroo.2026.03.039_bib42","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1161\/CIRCULATIONAHA.123.066984","article-title":"Prevention of sudden cardiac death: beyond automated external defibrillators and implantable cardioverter defibrillators","volume":"149","author":"Chugh","year":"2024","journal-title":"Circulation"},{"key":"10.1016\/j.hroo.2026.03.039_bib43","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.pcad.2025.06.005","article-title":"Sudden cardiac arrest: limitations in risk-stratification and treatment, and the potential for digital technologies and artificial intelligence to improve prediction and outcomes","volume":"91","author":"Srivats","year":"2025","journal-title":"Prog Cardiovasc Dis"}],"container-title":["Heart Rhythm O2"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666501826002539?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666501826002539?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T09:22:17Z","timestamp":1789723337000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666501826002539"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":43,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S2666501826002539"],"URL":"https:\/\/doi.org\/10.1016\/j.hroo.2026.03.039","relation":{},"ISSN":["2666-5018"],"issn-type":[{"value":"2666-5018","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Top developments in clinical cardiac electrophysiology\u20132025","name":"articletitle","label":"Article Title"},{"value":"Heart Rhythm O2","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hroo.2026.03.039","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc. on behalf of Heart Rhythm Society.","name":"copyright","label":"Copyright"}]}}